VALLOUREC: Vallourec announces the subscription price of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
VALLOUREC: Vallourec announces the subscription price of its employee share offering Value 16
   
  Press release
November 2016 www.vallourec.com
   

Vallourec announces the subscription price of its employee share offering Value 16

Boulogne-Billancourt (France), 7 November 2016 - Vallourec announces that the share subscription price within the framework of the Value 16 employee share offering has been fixed today by the Management Board.

The unit price of the shares is based on the reference price equal to the average opening Vallourec share price on the Euronext Paris over a period of twenty trading days from 10 October to 4 November 2016, included, discounted by 20% for the classic formula and 15% for the leverage formula, and rounded up to the immediately higher euro cent (the "Classic Formula Discounted Subscription Price" and the "Leverage Formula Discounted Subscription Price").

The average of the opening Vallourec share price during this period was €4.68. Therefore, the Classic Formula Discounted Subscription Price has been fixed at €3.75 and the Leverage Formula Discounted Subscription Price at €3.99.

The reservation period took place from 12 September to 30 September 2016, included. The subscription/revocation period of the capital increase, open to the beneficiaries of the Value 16 offer, will take place from 10 to 14 November 2016 included.

The implementation of the plan may result in the issuance of a maximum of 6,600,000 new shares and the grant of a maximum 15,000 existing free shares as a substitution of the employer contribution.

The capital increase is scheduled to take place on 14 December 2016.

Vallourec's ninth successive international employee share offering, Value 16, and description of its main features were announced in the press release issued on 28 July 2016. Employee shareholders today hold close to 2.56% of Vallourec's share capital.

About Vallourec

Vallourec is a world leader in premium tubular solutions for the energy markets and for demanding industrial applications such as oil & gas wells in harsh environments, new generation power plants, challenging architectural projects, and high-performance mechanical equipment. Vallourec's pioneering spirit and cutting-edge R&D open new technological frontiers. Operating in more than 20 countries, its 20,000 dedicated and passionate people work hand-in-hand with their customers to offer more than just tubes: they deliver innovative, safe, competitive and smart tubular solutions, to make every project possible.

Listed on Euronext in Paris (ISIN code: FR0000120354, Ticker VK) and eligible for the Deferred Settlement System (SRD), Vallourec is included in the following indices: SBF 120 and Next 150.

In the United States, Vallourec has established a sponsored Level 1 American Depositary Receipt (ADR) program (ISIN code: US92023R2094, Ticker: VLOWY). Parity between ADR and a Vallourec ordinary share has been set at 5:1.

vallourec.com Follow us on Twitter @Vallourec

For further information, please contact:

Investor relations                                             Press relations Etienne Bertrand                                                Héloïse Rothenbühler Tel: +33 (0)1 49 09 35 58                                    Tel: +33 (0)1 41 03 77 50 / +33 (0)6 45 45 19 67 etienne.bertrand@vallourec.com             heloise.rothenbuhler@vallourec.com

Individual shareholders Toll Free Number (from France): 0 800 505 110 actionnaires@vallourec.com                                                                                                                                                                                                                   

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...a66a709a5d

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 1

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 2

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 1

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 4

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
AI Trust in Finance: Survey Reveals Market Impact

Updated Category News Views 2

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Continue Reading
Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 3

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 2

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 0

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

Dynavax Encourages Support for Director Nominees Amid Changes

Updated Category News Views 112

Dynavax Urges Stockholders to Support Director Nominees Dynavax's Strategy is Delivering Significant Long-Term Stockholder Value Dynavax's Nominees Are Vastly Superior to Competitors' Candidates Across Every Critical Area Follow Recommendations of Proxy Advisory Firms and Vote "FOR" All Four of Dynavax's Director Nominees on the GOLD Proxy Card Today Dynavax Technologies...

Continue Reading
ION Achieves Landmark Certification for Algorithmic Trading

Updated Category News Views 171

ION Achieves Major Certification for Trading Software Globally recognized leader in trading technology, ION, has successfully secured certification as an Independent Software Vendor for algorithmic trading on BSE. This groundbreaking registration allows exchange members to leverage the advanced trading capabilities of ION's Fidessa trading platform, marking a pivotal step...

Continue Reading
ImmuCell Corporation Updates Lease and By-Laws: Key Insights

Updated Category News Views 128

ImmuCell Corporation Updates Lease Agreement and By-Laws ImmuCell Corporation (NASDAQ:ICCC) has embarked on a series of significant changes recently, including modifying the terms of its lease for the facility located in Portland, Maine. The company also took this opportunity to update its corporate by-laws, as revealed in a filing with the SEC. Revised Lease Agreement On...

Continue Reading
Navigating the Future of Zscaler: Options Insight and Performance

Updated Category News Views 157

Insights into Zscaler's Options Market Activity Recently, significant market players have exhibited a noticeably cautious outlook regarding Zscaler. The analysis of Zscaler's options history reveals intriguing patterns that might influence future trading decisions. Understanding the Options Trades In our examinations of the options trades associated with Zscaler (NASDAQ:...

Continue Reading
BPGbio Teams with Oxford University to Propel Protein Research Forward

Updated Category News Views 107

BPGbio and University of Oxford Collaborate on Groundbreaking Research BPGbio, Inc., a prominent, AI-driven clinical-stage biopharmaceutical company focusing on innovative mitochondrial biology and protein homeostasis, has officially entered into a strategic collaboration with the University of Oxford. This partnership aims to push the frontiers of research in protein...

Continue Reading